Prevalence of hypo- and hypermagnesemia in an Iranian urban population

Annals of Human Biology

Volumn 38, Issue 2, 2011, Pages 150-155

  Syedmoradi, Leila ^a   Ghasemi, Asghar ^a   Zahediasl, Saleh ^a   Azizi, Fereidoun ^a  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hypermagnesemia; Hypomagnesemia; Prevalence

Indexed keywords

MAGNESIUM;

DATA SET; GLUCOSE; HEALTH RISK; LIPID; MAGNESIUM; METABOLISM; NUTRITIONAL STATUS; PATHOLOGY; PHYSIOLOGY; SERUM; SPECTROPHOTOMETRY; URBAN POPULATION;

ADULT; AGED; ARTICLE; ATOMIC ABSORPTION SPECTROMETRY; BLOOD; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; EATING; FEEDING BEHAVIOR; FEMALE; GLUCOSE BLOOD LEVEL; HEALTH; HUMAN; HYPERTENSION; IRAN; MALE; MIDDLE AGED; MORPHOMETRICS; PREVALENCE;

ADULT; AGED; BLOOD GLUCOSE; BODY WEIGHTS AND MEASURES; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; EATING; FEMALE; FOOD HABITS; HUMANS; HYPERTENSION; IRAN; MAGNESIUM; MALE; MIDDLE AGED; PREVALENCE; SPECTROPHOTOMETRY, ATOMIC; URBAN HEALTH;

IRAN;

EID: 79551477142     PISSN: 03014460     EISSN: 14645033     Source Type: Journal    
DOI: 10.3109/03014460.2010.500472     Document Type: Article

References (37)

1. Azadbakht L, Mirmiran P, Hosseini F, Azizi F. 2005. Diet quality status of most Tehranian adults needs improvement. Asia Pac J Clin Nutr 14:163-168.
2. Azizi F, Rahmani M, Emami H, Madjid M. 2000. Tehran lipid and glucose study: Rationale and design. CVD Prevention 3:242-247.
3. Azizi F, Rahmani M, Emami H, Mirmiran P, Hajipour R, Madjid M, Ghanbili J, Ghanbarian A, Mehrabi Y, Saadat N, Salehi P, Mortazavi N, Heydarian P, Sarbazi N, Allahverdian S, Saadati N, Ainy E, Moeini S. 2002. Cardiovascular risk factors in an Iranian urban population: Tehran lipid and glucose study (phase 1). Soz Praventivmed 47:408-426. (Pubitemid 36285040)
4. Bo S, Durazzo M, Guidi S, Carello M, Sacerdote C, Silli B, Rosato R, Cassader M, Gentile L, Pagano G. 2006. Dietary magnesium and fiber intakes and inflammatory and metabolic indicators in middle-aged subjects from a population-based cohort. Am J Clin Nutr 84:1062-1069.
5. Classen HG. 2006. Protective effects of magnesium and orotic acid on the cardiovascular system and brain function. In: Porr PJ, Nechifor M, Durlach J, editors. Advances in magnesium research: New data. France: John Libbey. p 39-42.
6. Cole DE, Quamme GA. 2000. Inherited disorders of renal magnesium handling. J Am Soc Nephrol 11:1937-1947.
7. Corica F, Corsonello A, Ientile R, Cucinotta D, Di Benedetto A, Perticone F, Dominguez LJ, Barbagallo M. 2006. Serum ionized magnesium levels in relation to metabolic syndrome in type 2 diabetic patients. J Am Coll Nutr 25:210-215.
8. Dimke H, Hoenderop JG, Bindels RJ. 2010. Hereditary tubular transport disorders: Implications for renal handling of Ca2? and Mg2?. Authors J Compilation 118:1-18.
9. Elin RJ. 2001. Laboratory evaluation of chronic latent magnesium deficiency. In: Rayssiguier Y, Mazur A, Durlach LJ, editors. Advances in magnesium research: Nutrition and health. London: J. Libbey & Comp. p 233-239.
10. Esmaillzadeh A, Mirmiran P, Azizi F. 2005. Whole-grain intake and the prevalence of hypertriglyceridemic waist phenotype in Tehranian adults. Am J Clin Nutr 81:55-63.
11. Ford ES. 1999. Serum magnesium and ischaemic heart disease: Findings from a national sample of US adults. Int J Epidemiol 28: 645-651.
12. Ford ES, Mokdad AH. 2003. Dietary magnesium intake in a national sample of US adults. J Nutr 133:2879-2882.
13. Fox CH, Mahoney MC, Ramsoomair D, Carter CA. 2003. Magnesium deficiency in African-Americans: Does it contribute to increased cardiovascular risk factors? J Natl Med Assoc 95:257-262.
14. Friedewald WT, Levy RI, Fredrickson DS. 1972. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18: 499-502.
15. Ghasemi A, Zahediasl S, Azizi F. 2010. Reference values for serum magnesium levels in young adult Iranian subjects Biol Trace Elem Res [Epub ahead of print].
16. Glaudemans B, Knoers NV, Hoenderop JG, Bindels RJ. 2010. New molecular players facilitating Mg(2?) reabsorption in the distal convoluted tubule. Kidney Int 77:17-22.
17. Guerrero-Romero F, Rodriguez-Moran M. 2000. Hypomagnesemia is linked to low serum HDL-cholesterol irrespective of serum glucose values. J Diabetes Complicat 14:272-276.
18. Guerrero-Romero F, Rodriguez-Moran M. 2002. Low serum magnesium levels and metabolic syndrome. Acta Diabetol 39: 209-213.
19. Henrotte JG, Pla M, Dausset J. 1990. HLA- and H-2-associated variations of intra- and extracellular magnesium content. Proc Natl Acad Sci USA 87:1894-1898.
20. Huey CG, Chan KM, Wong ET, Nelson JM, Durand M. 1995. Los Angeles County-University of Southern California Medical Center clinical pathology case conference: Extreme hypermagnesemia in a neonate. Clin Chem 41:615-618.
21. Hunt BJ. 1969. The estimation of magnesium in plasma, muscle and bone, by atomic absorption spectrophotometry. Clin Chem 15: 979-996.
22. Hunter DJ, Lange M, Snieder H, MacGregor AJ, Swaminathan R, Thakker RV, Spector TD. 2002. Genetic contribution to renal function and electrolyte balance: A twin study. Clin Sci (Lond) 103: 259-265.
23. Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL, Brancati FL. 1999. Serum and dietary magnesium and the risk for type 2 diabetes mellitus: The Atherosclerosis Risk in Communities Study. Arch Intern Med 159:2151-2159.
24. Ma J, Folsom AR, Melnick SL, Eckfeldt JH, Sharrett AR, Nabulsi AA, Hutchinson RG, Metcalf PA. 1995. Associations of serum and dietary magnesium with cardiovascular disease, hypertension, diabetes, insulin, and carotid arterial wall thickness: The ARIC study. Atherosclerosis Risk in Communities Study. J Clin Epidemiol 48:927-940.
25. Mouw DR, Latessa RA, Hickner J. 2005. Clinical inquiries.What are the causes of hypomagnesemia? J Fam Pract 54:174-176.
26. Nerbrand C, Agreus L, Lenner RA, Nyberg P, Svardsudd K. 2003. The influence of calcium and magnesium in drinking water and diet on cardiovascular risk factors in individuals living in hard and soft water areas with differences in cardiovascular mortality. BMC Public Health 3:21.
27. Randell EW, Mathews M, Gadag V, Zhang H, Sun G. 2008. Relationship between serum magnesium values, lipids and anthropometric risk factors. Atherosclerosis 196:413-419.
28. Schimatschek HF, Rempis R. 2001. Prevalence of hypomagnesemia in an unselected German population of 16,000 individuals. Magnes Res 14:283-290.
29. Singh RB, Rastogi V, Singh R, Niaz MA, Srivastav S, Aslam M, Singh NK, Moshir M, Postiglione A. 1996. Magnesium and antioxidant vitamin status and risk of complications of ageing in an elderly urban population. Magnes Res 9:299-306.
30. Swaminathan R. 2003. Magnesium metabolism and its disorders. Clin Biochem Rev 24:47-66.
31. Topf JM, Murray PT. 2003. Hypomagnesemia and hypermagnesemia. Rev Endocr Metab Disord 4:195-206.
32. Vormann J. 2003. Magnesium: Nutrition and metabolism. Mol Aspects Med 24:27-37.
33. Wang J, Ruotsalainen S, Moilanen L, Lepisto P, Laakso M, Kuusisto J. 2007. The metabolic syndrome predicts cardiovascular mortality: A 13-year follow-up study in elderly non-diabetic Finns. Eur Heart J 28:857-864. (Pubitemid 47351113)
34. Wang JJ, Hu G, Lappalainen J, Miettinen ME, Qiao Q, Tuomilehto J. 2005. Changes in features of the metabolic syndrome and incident impaired glucose regulation or type 2 diabetes in a Chinese population. Diabetes Care 28:448-450.
35. Whang R, Ryder KW. 1990. Frequency of hypomagnesemia and hypermagnesemia. Requested vs routine. JAMA 263:3063-3064.
36. Wong ET, Rude RK, Singer FR, Shaw ST Jr. 1983. A high prevalence of hypomagnesemia and hypermagnesemia in hospitalized patients. Am J Clin Pathol 79:348-352.
37. Worwag M, Classen HG, Schumacher E. 1999. Prevalence of magnesium and zinc deficiencies in nursing home residents in Germany. Magnes Res 12:181-189.